Informed Choices. Better Outcomes. Wed, 14 Jun 2023 10:14:10 +0000 en-US hourly 1 https://wordpress.org/?v=6.7 https://xilis.com/wp-content/uploads/2021/05/cropped-favLogo-150x150.png 32 32 https://xilis.com/news/refractory-colorectal-cancer-patient-derived-microorganospheres-mostm-enables-correlation-of-targeted-therapy-combination-response-with-clinical-outcomes-2/ Sat, 10 Jun 2023 10:11:11 +0000 https://xilis.com/?post_type=news&p=1770 The post Refractory colorectal cancer patient-derived MicroOrganoSpheres (MOS)TM enables correlation of targeted therapy combination response with clinical outcomes appeared first on Xilis.

]]> The post Refractory colorectal cancer patient-derived MicroOrganoSpheres (MOS)TM enables correlation of targeted therapy combination response with clinical outcomes appeared first on Xilis.

]]> https://xilis.com/news/a-functional-immuno-oncology-io-assay-to-assess-patient-response-to-immunotherapeutics-in-metastatic-disease/ Sat, 10 Jun 2023 10:10:11 +0000 https://xilis.com/?post_type=news&p=1768 The post A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease appeared first on Xilis.

]]> The post A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease appeared first on Xilis.

]]> https://xilis.com/news/establishing-functional-models-of-peritoneal-carcinomatosis-using-microorganosphere-mos-technology/ Sat, 10 Jun 2023 09:46:52 +0000 https://xilis.com/?post_type=news&p=1763 The post Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology appeared first on Xilis.

]]> The post Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology appeared first on Xilis.

]]>